VISFO
Knowledge base
Burden of disease and unmet needs
Drive informed decision-making and effective resource allocation through comprehensive understanding of disease burden and unmet need.
Definition and criteria
A well-recognized, highly respected and trusted expert with significant influence in their field. KOLs are often thought leaders and educators, whose perceptions are likely to impact the opinions and decisions of others in their professional network. To be considered a KOL, an individual may fulfill some or even all of the following criteria:
Criteria 1
Criteria 2
Criteria 3
Criteria 4
Criteria 5
Criteria 6
Power your decision-making
with bespoke and intuitive intelligence boards
Visualize
VISFO combines cutting-edge technology and deep subject matter expertise to de-silo data and enable confident decision-making. With all outputs housed in our fully interactive, AI-enhanced knowledge base. Teams can drill down from high-level strategy to granular evidence, surfacing the right information in seconds.
Identify
- The clinical, humanistic, social, and economic burden of disease
- Diseases and patient populations characterized by a lack of suitable treatment options or inadequate treatments (limited by side effects, contraindications, or poor efficacy, for example)
Analyze
- Treatment pathways, guidelines, the patient journey and critical areas of demand
- The potential public health benefit of a new or improved treatment
- Likely market size and opportunities for competitive differentiation
Continuously track the disease burden and unmet need in your therapy area with user-defined data updates.
Use cases
How can this help your team...
Medical Affairs
Raise awareness about the impact of disease on patient lives and the need for better treatments
Enhance stakeholder engagement by presenting clear and compelling evidence of the burden of disease and unmet needs
Create educational resources for patients and healthcare providers based on burden of disease data
Market Access
Champion increased funding for research into neglected diseases with high unmet needs
Select clinical trial endpoints that align with the most pressing unmet needs, improving trial relevance and outcome measures
Prioritize the development of novel therapies addressing identified unmet needs
Clinical Development
Advocate for patient access to existing treatments and participate in discussions on drug pricing and reimbursement
Strengthen regulatory submissions with robust data demonstrating the need for new therapies
Provide evidence that your new therapy addresses key unmet needs to support your pricing and reimbursement negotiations with payers
See it in action with an interactive demo
See how VISFO’s precision intelligence and collaborative approach ensures you have the right insights, at the right time, to make the best possible strategic decisions.
